AMN director exercises RSUs, receives new RSU grant

AMN Healthcare Services director Jorge A. Caballero reported compensation-related equity activity.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

AMN Healthcare Services director Jorge A. Caballero reported compensation-related equity activity. On May 1, 2026, he exercised 8,325 Restricted Stock Units (RSUs), receiving the same number of AMN common shares, bringing his direct common stock holdings to 15,462 shares.

On the same date, he received a new award of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan, each representing one share of common stock upon vesting. The filing shows no share sales; activity consists of an RSU vesting/exercise and a new RSU grant tied to board service.

Insider Trade Summary

8,325 shares exercised/converted

Exercise 3 txns

Insider Caballero Jorge A.

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	8,325	$0.00	$0.00
Grant/Award	Restricted Stock Units	8,304	$0.00	$0.00
Exercise	Common Stock	8,325	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 8,304 contracts (Direct); Common Stock — 15,462 shares (Direct)

Footnotes (6)

F1. AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").
F2. The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.
F3. The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.
F4. RSUs do not have an expiration date.
F5. The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.
F6. The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027.

Key Figures

RSUs exercised into common stock: 8,325 shares Common shares held after transaction: 15,462 shares New RSU grant: 8,304 RSUs +2 more

5 metrics

RSUs exercised into common stock 8,325 shares RSU vesting and exercise on May 1, 2026

Common shares held after transaction 15,462 shares Direct ownership following RSU exercise

New RSU grant 8,304 RSUs Award under AMN Healthcare 2025 Equity Plan on May 1, 2026

Underlying shares for new RSUs 8,304 shares Each RSU represents one share of AMN common stock

RSUs exercised source grant date May 2, 2025 Original grant under AMN Healthcare 2017 Equity Plan

Key Terms

Restricted Stock Units, RSUs, AMN Healthcare 2017 Equity Plan, AMN Healthcare 2025 Equity Plan, +1 more

5 terms

Restricted Stock Units financial

"AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"Each RSU represents a contingent right to receive one share of AMN Common Stock."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

AMN Healthcare 2017 Equity Plan financial

"The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan."

AMN Healthcare 2025 Equity Plan financial

"The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan."

contingent right financial

"Each RSU represents a contingent right to receive one share of AMN Common Stock."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did AMN (AMN) director Jorge Caballero report?

Jorge A. Caballero reported exercising 8,325 Restricted Stock Units into AMN common stock and receiving a new grant of 8,304 RSUs. These transactions are compensation-related equity awards tied to his board service, with no open-market share sales disclosed in this filing.

Did AMN (AMN) director Jorge Caballero sell any shares in this Form 4?

The Form 4 shows no share sales by Jorge A. Caballero. It reports an RSU vesting and exercise for 8,325 shares of common stock and a separate grant of 8,304 new RSUs, both reflecting compensation rather than open-market selling activity.

How many AMN (AMN) shares does Jorge Caballero hold after these transactions?

After the RSU exercise, Jorge A. Caballero holds 15,462 shares of AMN common stock directly. He also has 8,304 RSUs outstanding from a new award, each representing a contingent right to receive one share upon future vesting conditions being met.

What are the terms of Jorge Caballero’s new AMN (AMN) RSU grant?

The new 8,304 RSUs granted on May 1, 2026 vest on the earlier of one year after the grant date or the company’s 2027 Annual Meeting of Shareholders. Each RSU represents a contingent right to receive one share of AMN common stock at vesting.

Under which plans were Jorge Caballero’s AMN (AMN) RSUs granted?

The RSUs that vested into 8,325 shares were granted under the AMN Healthcare 2017 Equity Plan, with vesting completed in 2026. The new 8,304 RSUs were granted under the AMN Healthcare 2025 Equity Plan, providing additional equity-based compensation for his director service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/04/2026 - 04:34 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caballero Jorge A.

(Last)

(First)

(Middle)

2999 OLYMPUS BLVD.

SUITE 500

(Street)

DALLAS

TEXAS

75019

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/01/2026		M⁽¹⁾		8,325	A	$0	15,462	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	05/01/2026		M			8,325	⁽³⁾	⁽⁴⁾	Common Stock	8,325	$0	0	D
Restricted Stock Units	⁽⁵⁾	05/01/2026		A		8,304		⁽⁶⁾	⁽⁴⁾	Common Stock	8,304	$0	8,304	D

Explanation of Responses:

1. AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

2. The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

3. The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

4. RSUs do not have an expiration date.

5. The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

6. The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027.

Remarks:

	/s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Jorge A. Caballero	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR